The Past Week's Notable Insider Buys Include Coupang, Keurig Dr Pepper, IPOs, And More

The Past Week's Notable Insider Buys Include Coupang, Keurig Dr Pepper, IPOs And More

Photo by Katherine Kromberg on Unsplash.

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets or the markets are near all-time highs.

With the earnings-reporting season over, plenty of insiders are now free to add to their stakes. Here are some of the most noteworthy insider purchases that were reported in the past week.

Prometheus Biosciences Inc saw several insiders, including 10% owners, directors, and an officer, acquire over $54.23 million worth of shares last week. That was more than 2.85 million shares of this San Diego-based biotech at the initial public offering price of $19 per share.

A beneficial owner at pharmaceutical company Innoviva Inc (INVA) stepped up to the buy window mid-week. That owner indirectly added more than 4.85 million shares to its stake, bringing it to over 6.15 million. At prices that averaged $3.25 per share, the transaction totaled nearly $13.93 million.

A group of directors and executives took advantage of a public offering of Merchants Bancorp (MBNC) stock. Altogether, they purchased 202,400 shares of this Indiana-based bank holding company. At $25 per share, that added up around $5.06 million. The bank has hiked its dividend as well.

A director returned last week to acquire another 71,800 or so PennyMac Financial Services Inc (PFSI) shares indirectly. At prices ranging from $64.75 to $65.28 per share, the total came to over $4.68 million. That same director bought more than 108,000 shares in the prior week.

After a disappointing earnings report earlier this month, GoHealth Inc (GOCO) CEO Clinton Jones and another director indirectly scooped up 356,000 shares altogether for $11.24 to $11.48 apiece. That added up to over $4.05 million. The stock closed Friday at $12.00 per share.

1 2
View single page >> |

Disclaimer: At the time of this writing, the author had no position in the mentioned equities.

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.